D&B Business Directory
Takeda Pharmaceuticals International AG
Overview
Takeda Pharmaceuticals International SA
From aching hearts to brittle bones, if you suffer from it, Nycomed probably has a drug to help. The Swiss pharmaceutical company develops prescription and OTC medicines mainly focusing on cardiology, gastroenterology, osteoporosis, respiratory, and pain management therapies. It operates nearly 20 facilities in a dozen European countries, where it conducts its own research and drug testing. It also develops products in conjunction with partner pharmaceutical companies. ...
Read More
The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies, as well as from licensing product rights to and from other companies. Nycomed was acquired by Japan's Takeda Pharmaceutical in 2011.
Read Less
Thomas Otto Claus Wozniewski   See more contacts
Management of Companies and Enterprises Holding companies, nec
?
?
Estimated

#
Modelled
? ?
Contacts
Get in Touch with 28 Principals*
  • Thomas Otto Claus Wozniewski
    Chairman of the Board
  • Contact 2
    ?
  • Contact 3
    ?
  • Contact 4
    ?
D&B Hoovers Logo

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Stay on top of your Business Credit File
Get full access to view your D&B business credit file now for just $39/month!
View D&B Scores & Ratings